User:Nbarajas303

Before securing a lead research position at Columbia University, Perry Hudson received surgical training in the Navy and obtained a research position in Urology at Johns Hopkins University under William Scott. Overtime, Hudson's desire to learn more about prostate cancer lead him to pursue a research position at Columbia University; where he lead various research projects and was given ownership of various labs. In addition to his academic accomplishments, Hudson was appointed head of urology at Francis Delafield Hospital. Hudson’s intent with the Skid Row cancer experiment was to figure out whether or not prostate cancer was terminal and how soon it could be diagnosed. He continued working in the urological field after leaving Colombia and also became involved in “tobacco research, laboratory science…[and] other major preventative research.”^[1] In addition, the efficacy of Hudson’s treatment for what he deemed “early” cancers using methods such as radical surgery, castration, and diethylstilbestrol therapy was still unknown at that time.^[2] However, despite this, Hudson’s studies were still cited in many urological journals and textbooks in the late 1950’s and 60’s as a new way to inspect the prostate. Only in a comment by the NIH in a response to one of Hudson’s requests for funding do they consider malpractice, asking for documentation of his compliance Public Health Service policy. Hudson has practiced in South Pasadena, Florida, Columbia University, New York City, and the Francis Delafield Hospital, in New York City. He is currently 98 years old and a board certified physician in North Carolina.^[3][4]